Ibogaine: Hope, Hype and the Need for Careful Science
The buzz around ibogaine, a plant‑derived drug from West Africa, exploded when a U. S. president highlighted its promise at a White House event that celebrated psychedelic research. For the first time, the Food and Drug Administration has cleared a clinical trial to test the substance in people.